+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cell Therapy Technologies Market by Product (Consumables, Equipment (Single-Use Equipment, Other Equipment), Systems & Software), Process (Cell Processing), Cell Type (T-cells, Stem Cells), End User (Research Institutes) - Global Forecast to 2025

  • ID: 5182932
  • Report
  • October 2020
  • Region: Global
  • 168 Pages
  • Markets and Markets
The Global Cell Therapy Technologies Market is Projected to Reach USD 5.6 Billion by 2025 from USD 2.8 Billion in 2020, at a CAGR of 14.4% from 2020 to 2025.

FEATURED COMPANIES

  • Avantor, Inc.
  • Corning Incorporated
  • Ixcells Biotechnology
  • Mak-System
  • Miltenyi Biotec GmbH
  • Sartorius Ag
  • MORE

The growth of this market is driven by the rising government investments in cell-based research, increasing incidence of chronic and infectious diseases, a large number of oncology-related cell therapy clinical trials, and increasing GMP certifications for cell therapy production facilities. Also, the emergence of iPSCs as an alternative to ESCs and increased focus on personalized medicine to offer an opportunity for the growth of the market during the forecast period.

Consumables are expected to hold the largest share of the cell therapy technologies market, by product in 2020.

On the basis of product, the market is segmented into consumables, equipment, and systems & software. The consumables segment accounted for the largest share of the cell therapy technologies market in 2019. Factors such as increasing investments by companies to develop advanced products as well as government initiatives for enhancing cell-based research are contributing to the growth of the cell therapy consumables market.

T-cells are expected to hold the largest share of the cell therapy technologies market, in 2020.

On the basis of cell type, the market is segmented into, T-cells, stem cells, and other cells. In 2019, T-cells accounted for the largest share of the cell therapy technologies market. Favorable government initiatives and the increasing demand for T-cell therapies are the key factors driving the growth of this segment.

Cell processing is expected to hold the largest share of the cell therapy technologies market in 2020.

On the basis of process, the market is segmented into cell processing, cell preservation, distribution and handling, and process monitoring and quality control. The cell processing segment dominated the market in 2019. This segment is expected to grow at the highest CAGR during the forecast period. The cell processing stage makes the highest use of cell therapy instruments and media, especially during culture media processing. This is the major factor responsible for the large share and high growth of this segment.

Biopharmaceutical & biotechnology companies and CROs segment commanded the largest share of the cell therapy technologies market in 2020

By end-user, the cell therapy technologies market is segmented into biopharmaceutical & biotechnology companies and CROs and research institutes and cell banks. Biopharmaceutical & biotechnology companies and CROs dominate the market and are expected to grow at the highest CAGR. The large share of this regional segment can primarily be attributed to the high burden of chronic diseases and increasing R&D activities in the pharmaceutical and biotechnology industries.

North America commanded the largest share of the cell therapy technologies market in 2020.

On the basis of region, the cell therapy technologies market is segmented into North America, Europe, Asia Pacific, and Rest of the World. In 2019, North America commanded the largest share of the cell therapy technologies market. The large share of this market segment can be attributed to the increasing incidence of CVD, increasing healthcare expenditure, growing disposable income, growing healthcare awareness, and the availability of technologically advanced devices in the region.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 (20%) , Tier 2 (45%), and Tier 3 (35%)
  • By Designation: C-level (30%), Director-level (20%), and Others (50%)
  • By Region: North America (35%), Europe (24%), AsiaPacific (25%), and RoW (16%).

Some of the major players operating in this market are Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany) and Danaher Corporation (US).

List of Companies Profiled in the Report

  • Thermo Fisher Scientific Inc. (US)
  • Merck KGaA (Germany)
  • MaxCyte (US)
  • Danaher Corporation (US)
  • Becton, Dickinson and Company (US)
  • Lonza Group (Switzerland)
  • Sartorius AG (Germany)
  • Terumo BCT (US)
  • Fresenius Medical Care AG & Co. KGaA (Germany)
  • Avantor, Inc. (US)
  • Bio-Techne Corporation (US)
  • Corning Incorporated (US)
  • FUJIFILM Irvine Scientific (US)
  • Werum IT Solutions GmbH (Germany)
  • RoosterBio Inc. (US)
  • SIRION Biotech GmbH (Germany)
  • CellGenix GmbH (Germany)
  • L7 Informatics, Inc. (US)
  • Miltenyi Biotec GmbH (Germany)
  • STEMCELL Technologies (Canada)
  • Hemasoft (US)
  • MAK-SYSTEM (US)
  • OrganaBio, LLC (US)
  • IxCells Biotechnology (China)
  • Wilson Wolf Corporation (US)

Research Coverage

This report studies the cell therapy technologies market based on product, cell type, process, end-user, and region. The report also analyzes factors (such as drivers, restraints, challenges, and opportunities) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total cell therapy technologies market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on cell therapy technologies offered by the top 25 players in the cell therapy technologies market. The report analyzes the cell therapy technologies market by product, cell type, process, end user, and region.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell therapy technologies market
  • Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the cell therapy technologies market

Frequently Asked Questions:

  • What are the growth opportunities in the cell therapy technologies market across major regions in the future?
  • Which type of cells are expected to hold the largest share in the cell therapy technologies market?
  • What are the various cell therapy technologies product types and their respective market shares in the overall market?
  • Which region has a well-developed cell therapy technologies market?
  • What is the impact of COVID-19 on cell therapy technologies market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Avantor, Inc.
  • Corning Incorporated
  • Ixcells Biotechnology
  • Mak-System
  • Miltenyi Biotec GmbH
  • Sartorius Ag
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Inclusions and Exclusions
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
1.7 Summary of Changes
1.8 Limitations of the Current Edition

2 Research Methodology
2.1 Research Data
Figure 1 Research Design
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
Figure 2 Breakdown of Primary Interviews: by Company Type, Designation, and Region
2.1.2.1 Key Data from Primary Sources
2.2 Market Size Estimation
Figure 3 Research Methodology: Hypothesis Building
2.2.1 Bottom-Up Approach
Figure 4 Cell Therapy Technologies Market: Bottom-Up Approach
2.2.2 Growth Forecast
2.2.3 Top-Down Approach
Figure 5 Cell Therapy Technologies Market: Top-Down Approach
2.3 Market Breakdown and Data Triangulation
Figure 6 Data Triangulation Methodology
2.4 Assumptions for the Study

3 Executive Summary
Figure 7 Cell Therapy Technologies Market, by Product, 2020 Vs. 2025 (USD Million)
Figure 8 Cell Therapy Technologies Market, by Cell Type, 2020 Vs. 2025 (USD Million)
Figure 9 Cell Therapy Technologies Market, by Process, 2020 Vs. 2025 (USD Million)
Figure 10 Cell Therapy Technologies Market, by End-user, 2020 Vs. 2025 (USD Million)
Figure 11 Cell Therapy Technologies Market, by Region, 2020 Vs. 2025 (USD Million)

4 Premium Insights
4.1 Cell Therapy Technologies: Market Overview
Figure 12 Large Number of Oncology-Related Cell Therapy Clinical Trials to Drive Market Growth During the Forecast Period
4.2 Asia-Pacific: Cell Therapy Technologies Market, by Product
Figure 13 Consumables to Dominate the Asia-Pacific Cell Therapy Technologies Market in 2019
4.3 Geographical Snapshot of the Cell Therapy Technologies Market
Figure 14 China to Register the Highest Growth Rate During the Forecast Period

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 15 Cell Therapy Technologies Market: Drivers, Restraints, Opportunities, and Challenges
5.2.1 Drivers
5.2.1.1 Rising Government Investments in Cell-Based Research
Table 1 Nih Funding for Cell-Based Research, 2016-2019 (USD Million)
5.2.1.2 Rising Incidence of Chronic and Infectious Diseases
Figure 16 Global Cancer Incidence, by Region, 2018 Vs. 2030
5.2.1.3 Large Number of Oncology-Related Cell Therapy Clinical Trials
Figure 17 Cancer Cell Therapy Pipeline (March 2019-March 2020)
5.2.1.4 Increasing Gmp Certifications for Cell Therapy Production Facilities
Table 2 Rising Manufacturing Certifications and Approvals for Gmp to Boost the Market
5.2.2 Restraints
5.2.2.1 High Cost of Cell-Based Research and Low Success Rate
Table 3 Cost of Cell Therapy Equipment
Table 4 Breakdown of Active Cell Therapy Clinical Trials, by Cell Group and Trial Phase
5.2.2.2 Dearth of Skilled Professionals
5.2.3 Opportunities
5.2.3.1 Emergence of IPSCs as an Alternative to ESCs
5.2.3.2 Increased Focus on Personalized Medicine
5.2.3.3 Increasing Public-Private Partnerships for the Development of Cell Therapies
5.2.3.4 Emerging Asian Markets
5.2.4 Challenges
5.2.4.1 Survival of Small Players and New Entrants
5.3 Value Chain Analysis
Figure 18 Value Chain Analysis: Major Value is Added During the Manufacturing and Assembly Phase
5.4 Supply Chain Analysis
Figure 19 Direct Distribution-The Preferred Strategy of Prominent Companies
5.5 Ecosystem Analysis
Figure 20 Ecosystem Analysis of the Biotechnology Industry
5.6 COVID-19 Impact Analysis
5.7 Regulatory Landscape
5.7.1 North America
Table 5 North America: Regulatory Landscape for Stem Cell Therapies
5.7.2 Europe
Table 6 Europe: Regulatory Landscape for Stem Cell Therapies
5.7.3 Asia-Pacific
Table 7 Asia-Pacific: Regulatory Landscape for Stem Cell Therapies
5.7.4 Row
Table 8 RoW: Regulatory Landscape for Stem Cell Therapies
5.8 Average Selling Price Trends
Table 9 Average Selling Price of Cell Processing Systems, 2019 Vs 2023 Vs 2025

6 Cell Therapy Technologies Market, by Product
6.1 Introduction
Table 10 Cell Therapy Technologies Market, by Product, 2018-2025 (USD Million)
6.2 Consumables
6.2.1 High Requirement of Consumables in Processes Supports Market Growth
Table 11 Cell Therapy Consumables Market, by Region, 2018-2025 (USD Million)
6.3 Equipment
Table 12 Cell Therapy Equipment Market, by Region, 2018-2025 (USD Million)
Table 13 Cell Therapy Equipment Market, by Type, 2018-2025 (USD Million)
6.3.1 Cell Processing Equipment
6.3.1.1 Cell Processing Equipment Dominates the Overall Equipment Market
Table 14 Cell Processing Equipment Market, by Region, 2018-2025 (USD Million)
6.3.2 Single-Use Equipment
6.3.2.1 Benefits of Single-Use Equipment Have Ensured End-User Demand
Table 15 Single-Use Equipment Market, by Region, 2018-2025 (USD Million)
6.3.3 Other Cell Therapy Equipment
Table 16 Other Cell Therapy Equipment Market, by Region, 2018-2025 (USD Million)
6.4 Systems & Software
6.4.1 Systems & Software are Used to Monitor the Different Stages of Cell Processing
Table 17 Cell Therapy Systems & Software Market, by Region, 2018-2025 (USD Million)

7 Cell Therapy Technologies Market, by Process
7.1 Introduction
Table 18 Cell Therapy Technologies Market, by Process, 2018-2025 (USD Million)
7.2 Cell Processing
7.2.1 Cell Processing Makes the Most Use of Cell Therapy Instruments
Table 19 Cell Therapy Technologies Market for Cell Processing, by Region, 2018-2025 (USD Million)
7.3 Cell Preservation, Distribution, and Handling
7.3.1 Increasing Demand for Cell-Based Medical Products and Therapies to Drive the Growth of the Segment
Table 20 Cell Therapy Technologies Market for Cell Preservation, Distribution, and Handling, by Region, 2018-2025 (USD Million)
7.4 Process Monitoring and Quality Control
7.4.1 Process Monitoring is Essential to Ensure the Quality and Accuracy of Cell Processing
Table 21 Cell Therapy Technologies Market for Process Monitoring and Quality Control, by Region, 2018-2025 (USD Million)

8 Cell Therapy Technologies Market, by Cell Type
8.1 Introduction
Table 22 Cell Therapy Technologies Market, by Cell Type, 2018-2025 (USD Million)
8.2 T-Cells
8.2.1 Research Conducted in the Field of Car-T Therapy Will Accelerate the Growth of the Segment
Table 23 T-Cell Therapy Technologies Market, by Region, 2018-2025 (USD Million)
8.3 Stem Cells
8.3.1 Increasing Funding in Stem Cell Research to Drive Market Growth
Table 24 Stem Cell Therapy Technologies Market, by Region, 2018-2025 (USD Million)
8.4 Other Cells
Table 25 Other Cell Therapy Technologies Market, by Region, 2018-2025 (USD Million)

9 Cell Therapy Technologies Market, by End-user
9.1 Introduction
Table 26 Cell Therapy Technologies Market, by End-user, 2018-2025 (USD Million)
9.2 Biopharmaceutical & Biotechnology Companies and Cros
9.2.1 Rising Number of Cell Therapy Manufacturing Facilities to Drive the Market
Table 27 Cell Therapy Technologies Market for Biopharmaceutical & Biotechnology Companies and Cros, by Region, 2018-2025 (USD Million)
9.3 Research Institutes and Cell Banks
9.3.1 Market Growth is Supported by Rising Research Activity
Table 28 Cell Therapy Technologies Market for Research Institutes and Cell Banks, by Region, 2018-2025 (USD Million)

10 Cell Therapy Technologies Market, by Region
10.1 Introduction
Table 29 Cell Therapy Technologies Market, by Region, 2018-2025 (USD Million)
10.2 North America
Figure 21 North America: Cell Therapy Technologies Market Snapshot
Table 30 North America: Cell Therapy Technologies Market, by Country, 2018-2025 (USD Million)
Table 31 North America: Cell Therapy Technologies Market, by Product, 2018-2025 (USD Million)
Table 32 North America: Cell Therapy Equipment Market, by Type, 2018-2025 (USD Million)
Table 33 North America: Cell Therapy Technologies Market, by Process, 2018-2025 (USD Million)
Table 34 North America: Cell Therapy Technologies Market, by Cell Type, 2018-2025 (USD Million)
Table 35 North America: Cell Therapy Technologies Market, by End-user, 2018-2025 (USD Million)
10.2.1 US
10.2.1.1 Increasing R&D Activities to Support Market Growth in the US
Table 36 US: Cell Therapy Technologies Market, by Product, 2018-2025 (USD Million)
Table 37 US: Cell Therapy Technologies Market, by Process, 2018-2025 (USD Million)
Table 38 US: Cell Therapy Technologies Market, by Cell Type, 2018-2025 (USD Million)
Table 39 US: Cell Therapy Technologies Market, by End-user, 2018-2025 (USD Million)
10.2.2 Canada
10.2.2.1 Increasing Government Funding to Drive the Adoption of Cell Therapy Instruments in Canada
Table 40 Canada: Cell Therapy Technologies Market, by Product, 2018-2025 (USD Million)
Table 41 Canada: Cell Therapy Technologies Market, by Process, 2018-2025 (USD Million)
Table 42 Canada: Cell Therapy Technologies Market, by Cell Type, 2018-2025 (USD Million)
Table 43 Canada: Cell Therapy Technologies Market, by End-user, 2018-2025 (USD Million)
10.3 Europe
Table 44 Europe: Cell Therapy Technologies Market, by Country, 2018-2025 (USD Million)
Table 45 Europe: Cell Therapy Technologies Market, by Product, 2018-2025 (USD Million)
Table 46 Europe: Cell Therapy Equipment Market, by Type, 2018-2025 (USD Million)
Table 47 Europe: Cell Therapy Technologies Market, by Process, 2018-2025 (USD Million)
Table 48 Europe: Cell Therapy Technologies Market, by Cell Type, 2018-2025 (USD Million)
Table 49 Europe: Cell Therapy Technologies Market, by End-user, 2018-2025 (USD Million)
10.3.1 Germany
10.3.1.1 Germany Holds the Largest Share of the European Market
Table 50 Germany: Cell Therapy Technologies Market, by Product, 2018-2025 (USD Million)
Table 51 Germany: Cell Therapy Technologies Market, by Process, 2018-2025 (USD Million)
Table 52 Germany: Cell Therapy Technologies Market, by Cell Type, 2018-2025 (USD Million)
Table 53 Germany: Cell Therapy Technologies Market, by End-user, 2018-2025 (USD Million)
10.3.2 UK
10.3.2.1 Favorable Funding and Investment Scenario in the UK Indicates Strong Growth in the Coming Years
Table 54 UK: Cell Therapy Technologies Market, by Product, 2018-2025 (USD Million)
Table 55 UK: Cell Therapy Technologies Market, by Process, 2018-2025 (USD Million)
Table 56 UK: Cell Therapy Technologies Market, by Cell Type, 2018-2025 (USD Million)
Table 57 UK: Cell Therapy Technologies Market, by End-user, 2018-2025 (USD Million)
10.3.3 France
10.3.3.1 Availability of Government and Private Support is a Key Driver of Market Growth
Table 58 France: Cell Therapy Technologies Market, by Product, 2018-2025 (USD Million)
Table 59 France: Cell Therapy Technologies Market, by Process, 2018-2025 (USD Million)
Table 60 France: Cell Therapy Technologies Market, by Cell Type, 2018-2025 (USD Million)
Table 61 France: Cell Therapy Technologies Market, by End-user, 2018-2025 (USD Million)
10.3.4 Italy
10.3.4.1 Initiatives Favoring Cell and Gene Therapy Development Will Support the Market in Italy
Table 62 Italy: Cell Therapy Technologies Market, by Product, 2018-2025 (USD Million)
Table 63 Italy: Cell Therapy Technologies Market, by Process, 2018-2025 (USD Million)
Table 64 Italy: Cell Therapy Technologies Market, by Cell Type, 2018-2025 (USD Million)
Table 65 Italy: Cell Therapy Technologies Market, by End-user, 2018-2025 (USD Million)
10.3.5 Spain
10.3.5.1 Increasing Funding from Private and Public Organizations to Aid Market Growth
Table 66 Spain: Cell Therapy Technologies Market, by Product, 2018-2025 (USD Million)
Table 67 Spain: Cell Therapy Technologies Market, by Process, 2018-2025 (USD Million)
Table 68 Spain: Cell Therapy Technologies Market, by Cell Type, 2018-2025 (USD Million)
Table 69 Spain: Cell Therapy Technologies Market, by End-user, 2018-2025 (USD Million)
10.3.6 Rest of Europe
Table 70 RoE: Cell Therapy Technologies Market, by Product, 2018-2025 (USD Million)
Table 71 RoE: Cell Therapy Technologies Market, by Process, 2018-2025 (USD Million)
Table 72 RoE: Cell Therapy Technologies Market, by Cell Type, 2018-2025 (USD Million)
Table 73 RoE: Cell Therapy Technologies Market, by End-user, 2018-2025 (USD Million)
10.4 Asia-Pacific
Figure 22 Asia-Pacific: Cell Therapy Technologies Market Snapshot
Table 74 Asia-Pacific: Cell Therapy Technologies Market, by Country, 2018-2025 (USD Million)
Table 75 Asia-Pacific: Cell Therapy Technologies Market, by Product, 2018-2025 (USD Million)
Table 76 Asia-Pacific: Cell Therapy Equipment Market, by Type, 2018-2025 (USD Million)
Table 77 Asia-Pacific: Cell Therapy Technologies Market, by Process, 2018-2025 (USD Million)
Table 78 Asia-Pacific: Cell Therapy Technologies Market, by Cell Type, 2018-2025 (USD Million)
Table 79 Asia-Pacific: Cell Therapy Technologies Market, by End-user, 2018-2025 (USD Million)
10.4.1 China
10.4.1.1 Increasing Cell Therapy-Based Trials to Support Market Growth in China
Table 80 China: Cell Therapy Technologies Market, by Product, 2018-2025 (USD Million)
Table 81 China: Cell Therapy Technologies Market, by Process, 2018-2025 (USD Million)
Table 82 China: Cell Therapy Technologies Market, by Cell Type, 2018-2025 (USD Million)
Table 83 China: Cell Therapy Technologies Market, by End-user, 2018-2025 (USD Million)
10.4.2 Japan
10.4.2.1 Rising Geriatric Population and Growing Disease Prevalence Will Drive the Market in Japan
Table 84 Japan: Cancer Incidence, by Type, 2018 Vs. 2025
Table 85 Japan: Cell Therapy Technologies Market, by Product, 2018-2025 (USD Million)
Table 86 Japan: Cell Therapy Technologies Market, by Process, 2018-2025 (USD Million)
Table 87 Japan: Cell Therapy Technologies Market, by Cell Type, 2018-2025 (USD Million)
Table 88 Japan: Cell Therapy Technologies Market, by End-user, 2018-2025 (USD Million)
10.4.3 Australia
10.4.3.1 Market in Australia to Benefit from Rising Investments in Medicine
Table 89 Australia: Cell Therapy Technologies Market, by Product, 2018-2025 (USD Million)
Table 90 Australia: Cell Therapy Technologies Market, by Process, 2018-2025 (USD Million)
Table 91 Australia: Cell Therapy Technologies Market, by Cell Type, 2018-2025 (USD Million)
Table 92 Australia: Cell Therapy Technologies Market, by End-user, 2018-2025 (USD Million)
10.4.4 Rest of Asia-Pacific
Table 93 RoAPAC: Cell Therapy Technologies Market, by Product, 2018-2025 (USD Million)
Table 94 RoAPAC: Cell Therapy Technologies Market, by Process, 2018-2025 (USD Million)
Table 95 RoAPAC: Cell Therapy Technologies Market, by Cell Type, 2018-2025 (USD Million)
Table 96 RoAPAC: Cell Therapy Technologies Market, by End-user, 2018-2025 (USD Million)
10.5 Rest of the World
Table 97 RoW: Cell Therapy Technologies Market, by Product, 2018-2025 (USD Million)
Table 98 RoW: Cell Therapy Equipment Market, by Type, 2018-2025 (USD Million)
Table 99 RoW: Cell Therapy Technologies Market, by Process, 2018-2025 (USD Million)
Table 100 RoW: Cell Therapy Technologies Market, by Cell Type, 2018-2025 (USD Million)
Table 101 RoW: Cell Therapy Technologies Market, by End-user, 2018-2025 (USD Million)

11 Competitive Landscape & Company Profiles
11.1 Competitive Landscape
11.1.1 Overview
Figure 23 Key Developments in the Cell Therapy Technologies Market, January 2017-September 2020
Figure 24 Market Evolution Framework: January 2017 to September 2020
11.1.2 Competitive Scenario
11.1.2.1 Agreements, Collaborations, and Partnerships
Table 102 Key Agreements, Collaborations, and Partnerships, January 2017-September 2020
11.1.2.2 Product Launches & Approvals
Table 103 Key Product Launches and Approvals, January 2017-September 2020
11.1.2.3 Expansions
Table 104 Key Expansions, January 2017-September 2020
11.1.2.4 Acquisitions
Table 105 Key Acquisitions, January 2017-September 2020
11.1.2.5 Other Developments
Table 106 Other Key Developments, January 2017-September 2020
11.1.3 Market Share Analysis
Figure 25 Cell Therapy Technologies Market Share Analysis, 2019
11.1.4 Company Evaluation Matrix
Figure 26 Cell Therapy Technologies Market (Global) Company Evaluation Matrix, 2019
11.1.5 Competitive Leadership Mapping (Start-Ups)
Figure 27 Cell Therapy Technologies Market: Competitive Leadership Mapping (Start-Ups), 2019
11.2 Company Profiles
(Business Overview, Products Offered, Recent Developments, and Analyst's View)*
11.2.1 Thermo Fisher Scientific
Figure 28 Thermo Fisher Scientific: Company Snapshot (2019)
11.2.2 Merck KGaA
Figure 29 Merck KGaA: Company Snapshot (2019)
11.2.3 Danaher Corporation
Figure 30 Danaher Corporation: Company Snapshot (2019)
11.2.4 Lonza Group
Figure 31 Lonza Group: Company Snapshot (2019)
11.2.5 Sartorius Ag
Figure 32 Sartorius Ag: Company Snapshot (2019)
11.2.6 Terumo Bct, Inc.
Figure 33 Terumo Corporation: Company Snapshot (2019)
11.2.7 Becton, Dickinson and Company
Figure 34 Becton, Dickinson and Company: Company Snapshot (2019)
11.2.8 Fresenius Medical Care AG & Co. KGaA
Figure 35 Fresenius Medical Care AG & Co. KGaA: Company Snapshot (2019)
11.2.9 Avantor, Inc.
Figure 36 Avantor, Inc.: Company Snapshot (2019)
11.2.10 Bio-Techne Corporation
Figure 37 Bio-Techne Corporation: Company Snapshot (2020)
11.2.11 Corning Incorporated
Figure 38 Corning: Company Snapshot (2019)
11.2.12 Fujifilm Irvine Scientific
Figure 39 Fujifilm Holdings Corporation: Company Snapshot (2019)
11.2.13 Maxcyte
Figure 40 Maxcyte: Company Snapshot (2019)
11.2.14 Werum It Solutions GmbH
Figure 41 Körber Ag: Company Snapshot (2019)
11.2.15 Roosterbio
11.2.16 Sirion Biotech GmbH
11.2.17 Cellgenix GmbH
11.2.18 L7 Informatics
11.2.19 Miltenyi Biotec GmbH
11.2.20 Stemcell Technologies
* Business Overview, Products Offered, Recent Developments, and Analyst's View Might Not be Captured in Case of Unlisted Companies.
11.2.21 Hemasoft
11.2.22 Mak-System
11.2.23 Organabio, LLC
11.2.24 Ixcells Biotechnology
11.2.25 Wilson Wolf Corporation

12 Appendix
12.1 Industry Insights
12.2 Discussion Guide
12.3 Knowledge Store: Subscription Portal
12.4 Available Customizations

Note: Product cover images may vary from those shown

Loading
LOADING...

  • Avantor, Inc.
  • Becton, Dickinson and Company
  • Bio-Techne Corporation
  • Cellgenix GmbH
  • Corning Incorporated
  • Danaher Corporation
  • Fresenius Medical Care AG & Co. KGaA
  • Fujifilm Irvine Scientific
  • Hemasoft
  • Ixcells Biotechnology
  • L7 Informatics
  • Lonza Group
  • Mak-System
  • Maxcyte
  • Merck KGaA
  • Miltenyi Biotec GmbH
  • Organabio, LLC
  • Roosterbio
  • Sartorius Ag
  • Sirion Biotech GmbH
  • Stemcell Technologies
  • Terumo Bct, Inc.
  • Thermo Fisher Scientific
  • Werum IT Solutions GmbH
  • Wilson Wolf Corporation
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll